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Abstract 
 
Background: The diagnosis of major depressive disorder (MDD), according to the Diagnostic and Statistical Manual of Mental 
Disorders, is based only on adult symptomatology of depression and not adapted for age and gender. This may contribute to 
the low diagnostic specificity and validity of adolescent MDD. In this study, we investigated whether latent classes based on 
symptoms associated with depressed mood could be identified in a sample of adolescents seeking psychiatric care, regardless 
of traditionally defined diagnostic categories. 
Methods: Self-reports of the Strengths and Difficulties Questionnaire and the Development and Well-Being Assessment 
were collected consecutively from all new patients between the ages of 13 and 17 years at two psychiatric outpatient clinics 
in Stockholm, Sweden. Those who reported depressed mood at intake yielded a sample of 21 boys and 156 girls. Latent 
class analyses were performed for all screening items and for the depression-specific items of the Development and Well-
Being Assessment.  
Results: The symptoms that were reported in association with depressed mood differentiated the adolescents into two 
classes. One class had moderate emotional severity scores on the Strengths and Difficulties Questionnaire and mainly 
symptoms that were congruent with the Diagnostic and Statistical Manual of Mental Disorders criteria for MDD. The other class 
had higher emotional severity scores and similar symptoms to those reported in the first class. However, in addition, this 
group demonstrated more diverse symptomatology, including vegetative symptoms, suicidal ideation, anxiety, conduct 
problems, body dysmorphic symptoms, and deliberate vomiting. The classes predicted functional impairment in that the 
members of the second class showed more functional impairment.  
Limitations: The relatively small sample size limited the generalizability of the results of this study, and the amount of 
items included in the analysis was restricted by the rules of latent class analysis. No conclusions about gender differences 
between the classes could be could be drawn as a result of the low number of boys included in the study.  
Conclusions: Two distinct classes were identified among adolescents with depressed mood. The class with highest 
emotional symptom severity score and the most functional impairment had a more diverse symptomatology that included 
symptoms that were not congruent with the traditional diagnostic criteria of MDD. However, this additional 
symptomatology is clinically important to consider. As a result, the clinical usefulness of the Diagnostic and Statistical Manual of 
Mental Disorders during the diagnostic process of adolescent depression is questioned.  
 
Keywords: Adolescent major depressive disorder, diagnostic validity, Diagnostic and Statistical Manual of Mental Disorders, latent 
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Introduction 
Depression is one of the most common mental 
health disorders among the adolescent population; it 
has a cumulative prevalence of 25% by the end of 
adolescence, and the prevalence of mild to 
moderate depression seems to be increasing (1;2). 
Depression during adolescence results in secondary 
problems, such as the loss of social, cognitive, and 
interpersonal skills; social problems; poor school 
performance; substance abuse; and difficulties with 
family and peer relationships. Adolescent 
depression is also related to a significantly increased 
risk of self-harm and suicide (1). The early onset of 
depressive symptoms in general is known to be 
associated with increased risk for suicide, increased 
treatment use, and psychiatric comorbidity as 
compared with the adult onset of major depressive 
disorder (MDD) (3).  
Neurodevelopmental aspects are important to 
consider in relation to adolescent depression. These 
include the course of adolescent brain maturation 
(including pruning), the maturation of the 
serotonergic and noradrenergic systems, and the 
mechanisms of hormonal impact on emotional 
regulation and stress sensitivity, which influence the 
expression of depression symptoms during puberty 
(4;5). In addition, genetic effects on symptoms of 
anxiety and depression are developmentally dynamic 
from middle childhood to young adulthood, thereby 
demonstrating both genetic innovation and genetic 
attenuation (6). A life-trajectory perspective of 
depression is important, because early exposure to 
environmental factors (e.g., developmental trauma, 
neglect, insecure attachment) may alter normal brain 
development and cause the dysregulation of affect 
and attention; these factors can result in an 
increased risk of depression, anxiety disorders, and 
attention-deficit/hyperactivity disorder later in 
childhood and during adolescence (7;8). The 
diagnostic criteria of the fourth and fifth editions of 
the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV and DSM-5) for MDD do not take age 
into consideration, despite that fact that the 
symptomatology of depression changes across the 
life span and seems to have a specific phenotype 
during adolescence that is quite different from the 
adult clinical symptomatology. 
There are specific concerns regarding the clinical 
use of DSM-IV and DSM-5 for the diagnosis of 
adolescent depression:  
1. The diagnosis of MDD during childhood and 
adolescence can be based only upon unspecific 
symptom criteria, which may contribute to an 
adverse effect on diagnostic specificity and 
treatment (9). Depressed mood and anhedonia are 
the two cardinal symptoms of MDD in adults. 
However, for children and adolescents, depressed 
mood may be substituted with irritable mood, 
which is not specific to MDD. Because only one of 
the cardinal symptoms is necessary for a diagnosis 
of MDD according to the DSM-IV and DSM-5, the 
MDD diagnosis can potentially be based on 
irritability and other symptoms that may occur with 
other psychiatric or somatic disorders as well.  
2. The symptom criteria of MDD are broadly 
defined and include reversed conditions. For 
example, a change in appetite and weight may be 
either weight loss/decreased appetite or weight 
gain/increased appetite; sleep problems may be 
early awakening, insomnia, late sleep phase, or 
hypersomnia. In addition, psychomotor inhibition 
and agitation are both MDD criteria. The broad 
definition of MDD leaves questions unanswered 
with regard to the diagnostic boundaries of the 
disorder (3).  
3. Psychiatric comorbidities are especially 
prevalent during adolescence (10). From a clinical 
point of view, it is often not clear which of the 
symptoms presented are expressions of adolescent 
MDD and which are expressions of psychiatric 
comorbidities, because many of the symptoms are 
unspecific and overlap among different diagnostic 
entities (11;12). Concentration difficulties, restless-
ness, hyperactivity, and a decrease in impulse 
control commonly coexist with MDD. In addition, 
the differential diagnosis of attention-deficit/ 
hyperactivity disorder and conduct disorder may be 
difficult, especially in children (10;13). Self-harming 
behavior (14), eating disorders (15), and substance 
abuse (16) frequently appear with MDD during 
adolescence. Generalized anxiety disorder and 
MDD often coexist and show diagnostic criteria 
overlap with regard to symptoms such as fatigue, 
concentration difficulties, irritability, and sleep 
disturbances (17-19).  
One example that illustrates a potentially 
counterproductive consequence of the clinical 
application of the DSM-IV and DSM-5 system for 
the diagnosis of adolescent psychiatric problems is 
the case of developmental trauma. From a 
neuroscientific and developmental point of view, it 
is known that early diverse life events cause limbic 
hyperactivation and hypercortisolemia and it is 
hypothesized that this is linked to damage of 
hippocampal neurons and depressive illness later in 
life (8;20-23). Following this trajectory, the 
pathophysiological processes involved may cause a 
diverse symptomatology that includes concentration 
difficulties, anxiety, and impulsivity. Secondary 
behavioral problems that are intended to self-sooth 
the primary problems (e.g., self-harming, behavioral 
problems, alcohol and drug abuse) are also common 
(7). From this perspective, the DSM categorization 
may not necessarily be clinically helpful; on the 
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contrary, it may complicate the situation for the 
patient with multiple psychiatric comorbidities. 
Future adolescent depression research should 
optimally aim to develop treatments that target the 
underlying neurodevelopmental dysfunction. 
Gender-specific symptom criteria are also lacking 
in the DSM system, which may have implications 
for nosology and therapeutics. Differences in gene-
tic risk factors for anxiety and depression in males 
and females may increase during development (6). 
Depressive symptoms in combination with features 
such as emotional instability and dysregulation, low 
impulse control, and elevated stress reactivity 
demonstrate increased prevalence at the onset of 
puberty, with a major predominance in girls; this is 
hypothesized to be related to estrogen effects and 
cortisol receptor sensitivity in the brain (24-27). In 
Sweden, the prevalence of self-assessed anxious and 
depressive symptoms as well as hospitalization for 
anxiety, depression, and suicide attempts have 
shown a more rapid and dramatic increase among 
adolescent females as compared with males during 
the last decade (28). In adults, women have a higher 
documented frequency of comorbid depression and 
anxiety disorders and a three-fold higher prevalence 
of atypical depression (29;30). To identify gender-
specific trajectories of depressive symptomatology 
and to define how the phenotype changes across 
the life span, we need to study which symptoms are 
associated with the depressive core symptoms 
during a defined age range and across genders.  
The primary aims of this study were to investigate 
which psychiatric symptoms are associated with 
depressed mood (regardless of traditionally defined 
diagnostic categories) in a sample of adolescents 
seeking psychiatric care and to investigate whether 
age-specific latent classes based on these symptoms 
could be identified. This analysis may help to define 
age-specific combinations of symptoms related to 
depressed mood while disregarding traditional 
diagnostic systems that are based on adult 
symptomatology. This may increase the chance of 
linking neuromechanisms to corresponding 
symptomatology and behavioral dysfunction, which 
may ultimately be useful for the development of 
targeted and effective treatment (31;32). 
Our first hypothesis was that latent class analysis 
(LCA) could identify particular classes of individuals 
on the basis of their symptom profile. In other 
words, we wanted to determine whether the 
symptoms may form meaningful classes, 
independently of prior theoretical expectations. 
LCA is a statistical method for identifying 
unmeasured class membership among subjects with 
the use of categorical and continuous observed 
variables. LCA can help to define subcategories of 
depression, such as depressed mood with self-
harming behavior, depressed mood with eating 
problems, or depressed mood with sleeping 
problems. LCA has previously been used with both 
large population-based samples (e.g., to define latent 
classes of episodic mania-like symptoms in children 
and adolescents (33), to assess variations in 
depression symptoms over the life courses of adults 
(34)) and smaller clinical samples (e.g., to assess 
treatment engagement (35), to determine diagnostic 
subgroups of patients with post-traumatic stress 
disorder (36)). Our second hypothesis was that the 
identified classes would be differentially predictive 
of social impairment. Finally, we hypothesized that 
the genders would be unevenly distributed between 
the classes. 
 
 
Methods 
Description of the sample and the data collection procedure  
The diagnostic self-assessment data for this study, 
which are discussed later in this article, were 
originally collected for a larger project that took 
place during 2009 and 2010. That study aimed to 
compare the efficacy of different intake procedures 
for new patients seeking help at the Stockholm 
Child and Adolescent Psychiatry Clinic, which is a 
public health care setting (37). Two outpatient 
clinics that covered two geographically different 
areas of Stockholm were assigned to let all new 
patients between the ages of 6 and 17 years old and 
their parents complete an intake procedure with the 
Strengths and Difficulties Questionnaire (SDQ) (38) 
and the Development and Well-Being Assessment 
(DAWBA) (39). Seven hundred and thirty-six 
patients and their parents were recruited 
consecutively and asked to complete the online 
versions of the SDQ and DAWBA at home before 
their first visit to the clinic. In the present study, we 
included the SDQ and DAWBA self-reports from 
all teenagers between the ages of 13 and 17 years 
who reported depressed mood (N = 177). The 
formulation in DAWBA that reflects depressed 
mood is “very sad, miserable, unhappy or tearful.” 
Depressed mood was chosen as the inclusion 
criteria for this study, because it is the most obvious 
and specific attribute of depressive disorders and 
regarded as a cardinal symptom of MDD. 
According to the DSM system, depressed mood can 
be exchanged for irritable mood in adolescents; 
however, because irritable mood is prevalent but 
non-specific to depression, it is inadequate as an 
inclusion criterion (9). Anhedonia, which is the 
other cardinal symptom of depression, is highly 
prevalent among depressed adolescents, but its 
extent is quite variable (40) and therefore also not a 
good inclusion criterion. The high variability of 
anhedonia with teenage depression could result in 
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contrasting MDD phenotypes, which we wanted to 
capture in the LCA.  
The Regional Ethical Review Board in Stockholm, 
Sweden, approved the study, and the research was 
conducted in accordance with the Helsinki 
Declaration as revised 1989. 
 
 
Measures  
The SDQ is a 25-item scale with subscales that 
reflect hyperactivity and inattention, behavior 
problems, emotional symptoms, peer problems, and 
pro-social behavior. The SDQ may also generate a 
total difficulties score by summarizing the scores of 
the subscales (except the pro-social subscale). The 
SDQ total impact score measures overall distress 
and social impairment caused by all mental health 
problems, specifically in the domains of family, 
school, learning, and leisure (41). The SDQ is 
considered psychometrically valid (42-44), and it is 
frequently used in the Nordic countries (45). In this 
study, the SDQ was administered before the 
DAWBA and used to ensure that the skipping rules 
were not overused (this is discussed in more detail 
later in this article). The SDQ was also used for the 
assessment of total difficulties and social 
impairment. 
The DAWBA (39) is an Internet-based semi-
structured interview that is compatible with the 
diagnostic criteria of the DSM-IV. Detailed 
information about the DAWBA is available from 
http://www.dawba.info; this includes online and 
downloadable versions of the measures and 
demonstrations of the clinical rating process. In this 
study, the DAWBA was used as a way to collect 
data about which symptoms were associated with 
depressed mood in adolescents who seek psychiatric 
care; the purpose was not to use it as a diagnostic 
tool. The DAWBA assesses separation anxiety; fears 
of specific things or situations; panic attacks and 
agoraphobia; post-traumatic stress; compulsions 
and obsessions; generalized anxiety; depression; 
attention and activity; conduct problems; and 
dieting, weight, and body/shape concerns. 
However, it does not address psychotic or autistic 
features or problems related to alcohol and drug 
abuse. The DAWBA focuses on current rather than 
lifetime problems. Each section starts with 
screening questions that allow the person 
completing the assessment to skip to the next 
section if the screening question is answered in the 
negative. If the screening is positive, additional 
specific questions are asked. Most sections of the 
DAWBA can only be skipped if the initial screening 
questions are negative and if the relevant SDQ 
score is close to average (i.e., <80th centile). This 
double requirement prevents “respondent fatigue,” 
which could result in too many sections being 
skipped (39). The depression section has screening 
questions for depressed mood, irritable mood, and 
anhedonia. If any of these three cardinal symptoms 
for MDD are rated positively, specific questions 
about other depression criteria follow (Table 1). The 
eating disorder section also has several screening 
questions about body dysmorphic symptoms, 
shame in relation to eating, deliberate vomiting, 
worries related to eating, and self-blame in relation 
to overeating.  
Depressed mood was used as the inclusion 
criterion for the study; irritable mood, anhedonia, 
and depression-specific items were also included as 
items in the analyses. Because two of the 
depression-specific items dealt with weight and 
appetite, we decided to have those two included in 
the LCA; in other words, not all five of the eating 
disorder screening questions were included due to 
limitations regarding the number of items allowed in 
the LCA. In summary, depressed mood was 
analyzed in relation to all other screening items 
except the five eating disorder items and in relation 
to the depression-specific items of the DAWBA. 
 
 
TABLE 1. The probability of having each of the self assessed symptoms, if 
belonging to class 1 or 2 respectively. Probabilities of >70% are marked in bold 
 
 Class 1 
n = 101 
Class 2 
n = 79 
   
Irritability .64 .89 
Loss of interest .86 .97 
Tired/no energy  .88 .99 
Change of appetite .53 .97 
Change of weight .21 .86 
Sleeping difficulties  .62 .85 
Sleep more than normal .29 .48 
Agitation  .46 .65 
Feelings of worthlessness .74 .96 
Concentration difficulties .77 .96 
Suicidal ideation .53 .90 
Concurrent or previous thoughts or action of self harming  .76 .97 
Specific fears .60 .90 
Symptoms of separation anxiety .23 .72 
Symptoms of social anxiety .34 .77 
Panic attacks during the last four weeks .41 .79 
Symptoms of agoraphobia .36 .72 
Experience of traumatic event .35 .53 
Symptoms of obsessive compulsive thoughts or behavior .23 .51 
Symptoms of generalized anxiety .91 .96 
Symptoms of hyperactivity .35 .52 
Conduct problems .53 .72 
 
 
The DAWBA has been translated to Swedish, and 
the Swedish version has been retranslated back into 
English and approved by Professor Goodman, who 
is the originator of the DAWBA. The Swedish 
DAWBA is in clinical use in several settings 
throughout Sweden, but no Swedish validation 
studies of this tool have yet been published (37). In 
Norway, the DAWBA has been shown to generate 
realistic estimates of the prevalence of psychiatric 
illness as well as a high predictive validity when used 
Latent Classes of Symptoms related to Clinically Depressed Mood 
 
23 
 
in public health settings (46). Good to excellent 
inter-rater reliability has been reported in 
Norwegian studies, with a κ value of 0.86 to 0.91 for 
any diagnoses and a κ value of 0.57 to 0.93 for 
emotional diagnoses (47). Another Norwegian study 
also demonstrated that experienced clinicians can 
assign reliable diagnoses and assess severity on the 
basis of DAWBA data that is collected online (48). 
 
Statistical analyses 
LCA simultaneously defines the structure and 
estimates the probabilities of membership in a 
certain class (49). LCA assumes the presence of 
discrete classes or groupings rather than 
dimensions. For example, it can be used to 
categorize people on the basis of their depressive 
symptoms into different subtypes of depressive 
symptomatology (i.e., latent classes). This can help 
to define subcategories of depression, such as 
depressive symptoms with self-harming behavior, 
depressive symptoms with eating problems, and 
depressive symptoms with sleeping problems. One 
can seek to explore the consequences of such a class 
membership: for instance, one may consider 
whether membership in the class of depressive 
symptomatology in combination with eating 
problems predicts other variables. There are 
different indices that can be used to evaluate how 
many classes are needed to best describe the data. 
Nylund and colleagues simulated multiple models 
and concluded that the Bayesian information 
criterion (BIC) performs best, irrespective of the 
number of classes and the sample size (50). BIC is a 
comparative measure that allows us to compare the 
fit of models with different numbers of classes. The 
model with the best fit has the lowest BIC value. 
LCA has specific limitations with regard to the 
number of included items in relation to sample size, 
and these limitations cannot be exceeded. In the 
current study, all individuals included in the LCA 
had a potential probability of 0 to 1 to endorse a 
specific item or symptom given their class 
membership. The cutoff for scoring positive on a 
symptom was 0.7 (i.e., a >70% probability of 
answering “yes”), given class membership. The 
Student t-test was used to evaluate mean differences 
in emotional symptoms, conduct problems, 
hyperactivity, peer problems, pro-sociability, and 
impact on function as measured with the SDQ. The 
frequencies of having symptoms specific to eating 
disorders were calculated for the total group to 
further investigate the findings of the LCA results. 
The relative risk ratios of having symptoms specific 
to eating disorders on the basis of class membership 
were also calculated retrospectively. 
 
 
Results  
To estimate the amount of classes that best 
described the data, six models were tested with BIC. 
The model with two distinct classes showed the 
best fit for the data (Table 2). The sample included 
21 boys and 156 girls, with a mean age of 15.0 years 
for the boys (standard deviation, 1.38; range, 13 to 
17 years) and 15.4 for the girls (standard deviation, 
1.37; range, 13 to 17 years). 
 
 
TABLE 2. ”Model-fit” using the Bayesian Information Criterion model (BIC) to 
test which amount of classes from 1 to six, that constitutes the best fit for the 
data  (lowest BIC score) 
 
Classes BIC 
 
1 2550.83 
2 2416.60 
3 2476.14 
4 2561.74 
5 2613.75 
6 2705.55 
 
 
 
LCA showed that, if an individual belonged to 
Class 1 (n = 99), the probability was high (>70%) 
that he or she would have symptoms of generalized 
anxiety, tiredness/loss of energy, loss of interest, 
concentration difficulties, previous or concurrent 
thoughts of self-harming or actual self-harming 
behavior, and feelings of worthlessness in addition 
to the predefined depressed mood (see Table 1).  
In Class 2 (n = 78), there was an even higher 
probability of having the same symptoms as those 
exhibited by the individuals in Class 1. However, 
what differed between the classes was the higher 
probability of the members of Class 2 having a 
greater diversity of symptoms. In addition to 
depressed mood and the previously described 
symptoms, changes of appetite and weight, suicidal 
ideation, irritability, sleeping problems, symptoms 
of anxiety expressed as specific fears, separation 
anxiety, social anxiety, panic attacks and 
agoraphobia, and conduct problems were also 
reported among members of Class 2 (see Table 1). 
There was a lower probability (64%) of problems 
with excessive sleeping, agitation, obsessive-
compulsive symptoms, and hyperactivity in both 
classes, and members of both groups often self-
reported having experienced or witnessed adverse 
or traumatic events (see Table 1). 
Symptom scores for self-assessment with the 
SDQ differed significantly between the classes. 
Members of Class 2 showed higher symptom 
severity for emotional symptoms, conduct 
problems, hyperactivity, and peer problems and 
lower scores for pro-social behavior. The total 
difficulties scores and impact scores were 
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significantly higher for members of Class 2 (see 
Table 3).  
 
 
TABLE 3. T-tests showing differences of mean-values of symptom severity  
between Class 1 and Class 2 assessed by Strengths and Difficulties  
Questionnaire (SDQ), including the subscales, the total difficulties score and 
impact on function 
 
 Class 1 
n = 99 
Class 2 
n = 78 
 
 
              Mean (SD) t-value 
    
SDQ-total 17.2 (5.2) 22.7 (5.3) 6.9*** 
SDQ-emotional symptoms 5.8 (2.1) 8.0 (1.6) 8.1*** 
SDQ-conduct problems 3.2 (2.0) 4.0 (2.1) 2.6** 
SDQ-hyperactivity 5.3 (2.6) 6.9 (2.2) 4.3*** 
SDQ-peer problem 2.9 (2.1) 3.8 (2.0) 3.2** 
SDQ-pro-social 7.4 (1.9) 7.4 (2.0) 0.1ns 
SDQ-impact on function 4.2 (2.7) 5.6 (2.6) 3.4*** 
*** p < .001, ** p < .01, * p < .05; SD=standard deviation; ns=non-significant 
 
 
 
Because problems with appetite and weight 
changes, which were both assessed by the 
depression-specific questions, demonstrated a major 
difference between the two classes, we decided to 
take a closer look at the five screening questions for 
eating disorders that were not included in the 
original LCA. We retrospectively analyzed how the 
answers to these five items were distributed 
between the two latent classes. It was discovered 
that members of Class 2 had more than double the 
risk of having body dysmorphic symptoms, shame 
related to eating behavior, self-induced vomiting, 
increased worrying about eating, and self-
accusations involving overeating as compared with 
Class 1 (Table 4). 
 
 
TABLE 4. Percentage of individuals in each class who has symptoms related to 
eating disorders and the relative risk of having the symptom when class 1 is 
used as reference 
 Class 1 
N = 88 
Class 2 
N = 73 
OR  
(95 % CI) 
    
1. Have you ever thought you were fat even when 
other people told you that you were very thin? 
59.1% 
(52) 
76.7% 
(56) 
2.15  
(1.07-4.32) 
2. Would you be ashamed if other people knew 
how much you eat? 
31.8% 
(28) 
54.8% 
(40) 
2.53  
(1.32-4.83) 
3. Have you ever deliberately made yourself 
vomit (throw up)? 
31.8% 
(28) 
54.8% 
(40) 
2.53  
(1.32-4.83) 
4. Do worries about eating (what? where? how 
much?) really interfere with your life? 
36.4% 
(32) 
67.1% 
(49) 
3.42  
(1.77-6.64) 
5. If you eat too much, do you blame yourself a 
lot? 
59.1% 
(52) 
76.7% 
(56) 
2.15  
(1.07-4.32) 
 
 
 
Discussion 
This study aimed to investigate which psychiatric 
symptoms were associated with depressed mood, 
regardless of traditionally defined diagnostic 
categories and whether age-specific diagnostic latent 
classes that were based on these symptoms could be 
identified. This is of importance because the 
diagnostic entity of MDD as defined by adult DSM 
criteria does not well match the symptomatology 
that adolescents present in conjunction with 
depressed mood; in addition, the boundaries of how 
these symptoms are expressed among individuals 
with comorbid disorders are not clear cut 
(10;15;51). We investigated whether age-specific 
diagnostic latent classes could be identified on the 
basis of a broad variety of symptoms, including 
symptoms that are not traditionally regarded as 
depression criteria. Some of these have, in previous 
research, been shown to frequently co-occur with 
depressive problems in adolescents, such as 
attention-deficit/hyperactivity disorder, anxiety, and 
eating disorders (13;15;52;53). Our study yielded 
two main results. First, LCA of the psychiatric 
symptoms differentiated the adolescents with 
depressed mood into two distinct classes that 
differed with regard to emotional symptom severity 
and diversity of symptoms. Second, the classes 
predicted social impairment; Class 2 had higher 
general symptom severity and greater impact on 
function related to family, school, learning, and 
leisure. Our third hypothesis that the genders would 
be unevenly distributed between the classes was not 
confirmed as a result of the relatively small number 
of boys included in the study. 
The results of the LCA that included a broad 
range of psychiatric symptoms in adolescents with 
depressed mood and who were seeking psychiatric 
care differentiated the adolescents into two distinct 
classes, which supported our first hypothesis. Class 
1 had symptoms that reflected the established DSM 
criteria for MDD, such as tiredness/loss of energy, 
loss of interest, concentration difficulties, previous 
or concurrent thoughts of self-harm or actual self-
harming behavior, and feelings of worthlessness. 
Class 2, on the other hand, had all of the same 
symptoms as Class 1 in addition a more diverse 
symptomatology that included irritability, suicidal 
ideation, conduct problems, symptoms of anxiety 
expressed as specific fears, separation anxiety, social 
anxiety, and panic attacks and agoraphobia. Class 2 
also had a high probability of having vegetative 
symptoms, such as changes of appetite and weight 
and sleeping problems. Members of Class 2 also had 
a higher risk of having body dysmorphic symptoms, 
deliberate vomiting, increased worrying, and shame 
related to eating. These findings are in line with 
previous studies that have demonstrated that binge 
eating is related to emotional dysregulation (54) and 
that the comorbidity of depressed mood and eating-
related symptoms is high in this age group (15). 
There was also a high probability of sleeping 
problems among the members of Class 2. Sleeping 
problems should be carefully addressed at intake, 
because they may have a reciprocal relationship with 
emotional dysregulation and explain the increase in 
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self-reported tiredness and concentration difficulties 
(55;56). 
Our second hypothesis that the latent classes of 
adolescent depression are predictive of symptom 
severity and social impairment was also supported 
by our findings. Indeed, one may speculate that the 
symptomatology of Class 1 represents a milder form 
of depression, with its own trajectory, and that the 
more severe Class 2 (as defined by the emotional 
subscale of SDQ) describes the age-specific 
symptom profile of melancholic depression, with 
more suicidal ideation and vegetative symptoms. If 
that is the case, it is of clinical importance to 
recognize the diversity of symptoms that present 
with adolescent melancholic depression as 
compared with the typical adult features. According 
to our data, symptoms related to severe depression 
during adolescence include conduct problems, 
anxiety and panic attacks, agoraphobia, specific 
fears, social as well as generalized anxiety, and 
symptoms related to eating and sleeping. Binge 
eating and deliberate vomiting often occur in 
adolescents of normal weights; these features are 
closely related to shame and should be specifically 
asked about during intake. Sleep disturbances in 
adolescents are also important to identify and treat, 
because they are related to an increased risk of 
suicide (57).  
It has been suggested that adolescent melancholic 
depression may be a discrete category at the 
extreme end of the depression spectrum (58). If 
melancholic depression during adolescence is 
defined by the symptoms demonstrated by the 
members of Class 2, then this may be a possibility in 
line with our findings. Interestingly, anhedonia - 
which is a cardinal symptom of adolescent MDD 
according to DSM and regarded as a typical feature 
of melancholic depression in adults - occurred very 
frequently in both classes. However, irritability - 
which is also regarded as a cardinal symptom of 
adolescent depression - was not reported as 
frequently, and it was predominantly found in the 
members of the more severely depressed group. 
The notion that adolescent MDD is a purely 
dimensional construct (58) was not supported by 
our data.  
Unfortunately, our third hypothesis regarding 
gender distribution across the classes could not be 
confirmed as a result of the relatively small number 
of boys included in the study. The ratio of boys and 
girls in the total sample was 21 to 156, which 
mirrors the gender distribution of depressed teenage 
patients in child psychiatry treatment in Sweden 
(59). It may also be the case that teenage boys with 
depression have a different symptom profile that 
includes substance abuse as well as behavioral and 
conduct problems that make them less inclined to 
seek psychiatric care (60). Suicide rates are four 
times higher among boys as compared with girls 
between the ages of 16 and 18 years in the United 
States, but girls have higher rates of suicidal ideation 
and attempted suicide (61).  
The lack of adaptation for ontogenetic aspects 
and age in the MDD diagnostic criteria of DSM-IV 
and DSM-5 may contribute to a low diagnostic 
specificity and validity for MDD during 
adolescence. Consequently, the DSM system may 
have limited the opportunity to identify trajectories 
of the progression of depressive problems across 
adolescence into young adulthood and thus 
hampered the ability to estimate prognosis and to 
develop efficient treatment (62). Furthermore, when 
treatments that are shown to be effective for adult 
MDD are applied to adolescent MDD defined by 
adult criteria, there is considerable risk that young 
people who are not suffering from MDD will 
receive antidepressant medication. In fact, selective 
serotonin reuptake inhibitor treatment of adolescent 
MDD (as defined by the DSM system) has not 
demonstrated clear evidence of the reduction of 
depressive symptoms as compared with placebo, 
and it is not known whether selective serotonin 
reuptake inhibitors decrease the risk of suicide in 
this population (32;63). The situation may look 
different if new treatments for adolescent 
depression were targeted for populations that were 
defined by age-appropriate symptom profiles and 
their underlying pathophysiologies.  
The rationales of the DSM-IV and DSM-5 
diagnostic systems have recently been heavily 
debated, and the National Institute of Mental 
Health has launched a strategic plan (Strategy 1.4) to 
develop new ways of classifying mental disorders on 
the basis of dimensions of observable behavior as 
well as neurobiological measures. (For the full text 
of this plan, visit http://www.nimh.nih.gov/about/ 
strategic-planning-reports/index.shtml.) The Research 
Domain Criteria Project of the National Institute of 
Mental Health aims to establish construct validity 
for dimensions of psychopathology by promoting 
clinical research in which subjects are recruited 
transdiagnostically on the basis of the specific 
research question. Developmental and gender 
aspects are not included in these criteria, but it is 
stated that an intended focus is to enhance a 
systematic integration of developmental aspects and 
interactions with the environment and their 
relationship to specific brain circuits and functions.  
A limitation of this study is its relatively small 
sample size. The results have to be replicated with 
the use of larger samples and recruited from more 
diverse locations to be generalizable. The relatively 
small sample size also limited the amount of items 
that could be included in the LCA. The small 
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number of boys in the study made comparisons 
between genders underpowered, and no conclusions 
could be drawn regarding symptom differences 
between boys and girls. Another limitation is that 
the DAWBA does not assess autistic and psychotic 
symptoms or alcohol and drug abuse. These 
problems may have been co-occurring among 
individuals with depressed mood in this study’s 
cohort, but they have not been taken into 
consideration during our analysis. 
In summary, LCAs of psychiatric symptoms in 
teenagers with depressed mood showed two distinct 
classes. One group demonstrated tiredness/loss of 
energy, feelings of worthlessness, concentration 
difficulties, previous or concurrent thoughts of self-
harming or actual self-harming behavior, 
generalized anxiety, and less functional impairment 
as compared with the other group. The second 
group had similar symptoms but greater symptom 
variations, including vegetative symptoms and 
suicidal ideation; this group’s members also had 
greater functional impairment. No conclusions 
about gender distribution could be drawn as a result 
of the small number of boys included in the study. 
These findings show that age-specific symptoms 
outside of the traditionally defined MDD criteria are 
important to consider during the diagnostic process 
for teenage depression, and they point to the 
difficulty of defining adolescent MDD as a precise 
diagnostic entity when employing adult DSM-IV 
and DSM-5 standards. The clinical utility of the 
DSM-IV and DSM-5 systems for the diagnosis of 
teenage depression is limited as a result of the low 
diagnostic validity and specificity of the symptom 
criteria for this age group. Future studies of teenage 
depression should be based on dimensions of 
psychopathology and their behavioral aspects as 
recognized by transdiagnostic investigations. 
However, both developmental and gender aspects 
as well as interaction with the environment must be 
taken into consideration to gain a better 
understanding of the trajectories of symptom 
expression and disease progression across the life 
span and, ultimately, to aid in the development of 
targeted prevention and treatment. 
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